The largest database of trusted experimental protocols

Anti mir 506 3p

Manufactured by RiboBio
Sourced in China

Anti-miR-506-3p is a laboratory reagent designed to target and inhibit the expression of miR-506-3p, a microRNA molecule. Its core function is to provide a tool for researchers to modulate the levels of miR-506-3p in their experimental systems.

Automatically generated - may contain errors

3 protocols using anti mir 506 3p

1

Targeting DLX6-AS1 and miR-506-3p in Neuroblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interference RNA targeting DLX6-AS1 (si-DLX6-AS1: 5ʹ-AAUAAAGAACACUUACACUACUG-3ʹ) together with its negative control (si-NC: 5ʹ- UUCUCCGAACGUGUCACGUTT-3ʹ) were assembled by Ribobio (Guangzhou, China). miR-506-3p mimics (miR-506-3p; Product ID: miR10002878-1-5), miR-506-3p inhibitors (anti-miR-506-3p; Product ID: miR20002878-1-5) and respective controls, including miR-NC (Product ID: miR1N0000001-1-5) and anti-miR-NC (Product ID: miR2N0000001-1-5) were purchased from Ribobio. The sequences of DLX6-AS1 and STAT2 were amplified and cloned into the pcDNA3.1 overexpression vector, named as pcDNA-DLX6-AS1 and pcDNA-STAT2 (Sangon, Shanghai, China), and pcDNA empty vector was served as the negative control (pcDNA-NC). For stable DLX6-AS1 knockdown, a lentiviral vector containing short hairpin RNA targeting DLX6-AS1 (sh-DLX6-AS1: 5ʹ-GGTTCAGTATAGATTTCTA-3ʹ) and its negative control (sh-NC: 5ʹ- TTCTCCGAACGTGTCACGT-3ʹ) were synthesized by Research-Bio Co., Ltd (Shanghai, China). These oligonucleotides (20 nM) and plasmids (1 µg) were transfected into SK-N-SH and LAN-6 cells (5×104 cells) using Lipofectamine 3000 Reagent (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
2

Targeting Circular RNA circ_0003928 and miR-506-3p in HK-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The small interfering RNA against circ_0003928 (si-circ_0003928, 5′-AAGAGGATGGCCCCAGAAGTA-3′), the mimics of miR-506-3p (miR-506-3p, 5′-UAAGGCACCCUUCUGAGUAGA-3′), the inhibitors of miR-506-3p (anti-miR-506-3p, 5′-UCUACUCAGAAGGGUGCCUUA-3′), and respective controls, including siRNA negative control (si-NC), the negative control of miRNA mimics (miR-NC) and the negative control of miRNA inhibitors (anti-miR-NC) were synthesized in Ribobio Co., Ltd. (Guangzhou, China). The open reading frame of HDAC4 was amplified and then inserted into the pcDNA 3.1 vector by GenePharma Co., Ltd. (Shanghai, China) to generate the overexpression plasmid of HDAC4 (HDAC4). Then, cell transfection was performed on HK-2 cells in accordance with the manufacturer’s direction of FuGENE6 (Roche, Basel, Switzerland).
+ Open protocol
+ Expand
3

Modulating circUBAP2 and SEMA6D in CDDP-resistant Osteosarcoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNA (siRNA) against circUBAP2#1/2 (si-circUBAP2#1/2) and its negative control (si-NC), SEMA6D overexpression plasmid (SEMA6D) and its negative control (pcDNA), miR-506-3p mimic and inhibitor (miR-506-3p and anti-miR-506-3p) or their negative controls (miR-NC and anti-miR-NC) were synthesized by Ribobio (Guangzhou, China). All plasmid vectors were transfected into U2OS/CDDP and SaOS-2/CDDP cells using Lipofectamine 3000 (Invitrogen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!